BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23012969)

  • 1. [Toll like receptors and malaria parasites invasion: progress and prospective].
    Sun F; Xu BH
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Jun; 24(3):358-61. PubMed ID: 23012969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity.
    Erdman LK; Finney CA; Liles WC; Kain KC
    Mol Biochem Parasitol; 2008 Dec; 162(2):105-11. PubMed ID: 18804125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria.
    Leoratti FM; Farias L; Alves FP; Suarez-MĂștis MC; Coura JR; Kalil J; Camargo EP; Moraes SL; Ramasawmy R
    J Infect Dis; 2008 Sep; 198(5):772-80. PubMed ID: 18662133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of host innate immune responses by the malaria parasite.
    Coban C; Ishii KJ; Horii T; Akira S
    Trends Microbiol; 2007 Jun; 15(6):271-8. PubMed ID: 17466521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of malaria parasites. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1987; 743():1-229. PubMed ID: 3109131
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitness costs of resistance to antimalarial drugs.
    Felger I; Beck HP
    Trends Parasitol; 2008 Aug; 24(8):331-3. PubMed ID: 18603474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
    Babiker HA; Hastings IM; Swedberg G
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):581-93. PubMed ID: 19485798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-cell invasion by malaria parasites: insights from Plasmodium and Toxoplasma.
    Baum J; Gilberger TW; Frischknecht F; Meissner M
    Trends Parasitol; 2008 Dec; 24(12):557-63. PubMed ID: 18835222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria.
    Ropert C; Franklin BS; Gazzinelli RT
    Semin Immunopathol; 2008 Feb; 30(1):41-51. PubMed ID: 18071705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On inducible variations in genetics of malaria parasites from the view of emergence of chloroquine].
    Yan JZ; Li M; Song GH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(6):363-5. PubMed ID: 12567617
    [No Abstract]   [Full Text] [Related]  

  • 13. Malarial protease inhibitors: potential new chemotherapeutic agents.
    Sharma A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug resistant malaria].
    Kano S
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():214-20. PubMed ID: 12717974
    [No Abstract]   [Full Text] [Related]  

  • 15. Malaria. Chloroquine makes a comeback.
    Vogel G
    Science; 2006 Nov; 314(5801):904. PubMed ID: 17095662
    [No Abstract]   [Full Text] [Related]  

  • 16. Should chloroquine be laid to rest?
    Ginsburg H
    Acta Trop; 2005 Oct; 96(1):16-23. PubMed ID: 16054105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The malarial metabolite hemozoin and its potential use as a vaccine adjuvant.
    Coban C; Yagi M; Ohata K; Igari Y; Tsukui T; Horii T; Ishii KJ; Akira S
    Allergol Int; 2010 Jun; 59(2):115-24. PubMed ID: 20414048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origins of antimalarial drug resistance.
    Hastings IM
    Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets.
    Ding XC; Beck HP; Raso G
    Trends Parasitol; 2011 Feb; 27(2):73-81. PubMed ID: 21169061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity of malaria transmission and the evolution of drug resistance.
    Hastings IM; Watkins WM
    Acta Trop; 2005 Jun; 94(3):218-29. PubMed ID: 15847846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.